142 related articles for article (PubMed ID: 21333270)
1. Increased expression of Toll-like receptor-9 has close relation with tumour cell proliferation in oral squamous cell carcinoma.
Min R; Zun Z; Siyi L; Wenjun Y; Lizheng W; Chenping Z
Arch Oral Biol; 2011 Sep; 56(9):877-84. PubMed ID: 21333270
[TBL] [Abstract][Full Text] [Related]
2. The secretion of IL-6 by CpG-ODN-treated cancer cells promotes T-cell immune responses partly through the TLR-9/AP-1 pathway in oral squamous cell carcinoma.
Ruan M; Thorn K; Liu S; Li S; Yang W; Zhang C; Zhang C
Int J Oncol; 2014 Jun; 44(6):2103-10. PubMed ID: 24676671
[TBL] [Abstract][Full Text] [Related]
3. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
4. Increased Cyfra 21-1 concentration in saliva from primary oral squamous cell carcinoma patients.
Zhong LP; Zhang CP; Zheng JW; Li J; Chen WT; Zhang ZY
Arch Oral Biol; 2007 Nov; 52(11):1079-87. PubMed ID: 17612501
[TBL] [Abstract][Full Text] [Related]
5. Evaluation of survivin as a prognostic marker in oral squamous cell carcinoma.
Kim YH; Kim SM; Kim YK; Hong SP; Kim MJ; Myoung H
J Oral Pathol Med; 2010 May; 39(5):368-75. PubMed ID: 20050981
[TBL] [Abstract][Full Text] [Related]
6. High stromal versican expression predicts unfavourable outcome in oral squamous cell carcinoma.
Pukkila M; Kosunen A; Ropponen K; Virtaniemi J; Kellokoski J; Kumpulainen E; Pirinen R; Nuutinen J; Johansson R; Kosma VM
J Clin Pathol; 2007 Mar; 60(3):267-72. PubMed ID: 16731595
[TBL] [Abstract][Full Text] [Related]
7. [Investigation of CXCR4 in oral squamous cell carcinoma and its influence on proliferation of tumor cells in vitro].
Xu M; Li WY; Chen XM; Wang XH; Huang J; Wang L
Zhonghua Kou Qiang Yi Xue Za Zhi; 2006 Jun; 41(6):372-5. PubMed ID: 16836911
[TBL] [Abstract][Full Text] [Related]
8. Increased Toll-like receptor 9 expression indicates adverse prognosis in oesophageal adenocarcinoma.
Kauppila JH; Takala H; Selander KS; Lehenkari PP; Saarnio J; Karttunen TJ
Histopathology; 2011 Oct; 59(4):643-9. PubMed ID: 22014045
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor a and proliferation marker in prediction of lymph node metastasis in oral and pharyngeal squamous cell carcinoma.
Boonkitticharoen V; Kulapaditharom B; Leopairut J; Kraiphibul P; Larbcharoensub N; Cheewaruangroj W; Chintrakarn C; Pochanukul L
Arch Otolaryngol Head Neck Surg; 2008 Dec; 134(12):1305-11. PubMed ID: 19075127
[TBL] [Abstract][Full Text] [Related]
10. Expression of melanoma-associated antigens in oral squamous cell carcinoma.
Ries J; Vairaktaris E; Mollaoglu N; Wiltfang J; Neukam FW; Nkenke E
J Oral Pathol Med; 2008 Feb; 37(2):88-93. PubMed ID: 18197853
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of expression of midkine in oral squamous cell carcinoma and its correlation with tumour angiogenesis.
Ruan M; Ji T; Wu Z; Zhou J; Zhang C
Int J Oral Maxillofac Surg; 2007 Feb; 36(2):159-64. PubMed ID: 17110085
[TBL] [Abstract][Full Text] [Related]
12. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
13. Ki-67 from clinically and histologically "normal" distant mucosa as prognostic marker in early-stage (T1-T2N0) oral squamous cell carcinoma: a prospective study.
Montebugnoli L; Gissi DB; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
J Oral Maxillofac Surg; 2011 Oct; 69(10):2579-84. PubMed ID: 21292374
[TBL] [Abstract][Full Text] [Related]
14. Prognostic value of Ki67 from clinically and histologically 'normal' distant mucosa in patients surgically treated for oral squamous cell carcinoma: a prospective study.
Montebugnoli L; Badiali G; Marchetti C; Cervellati F; Farnedi A; Foschini MP
Int J Oral Maxillofac Surg; 2009 Nov; 38(11):1165-72. PubMed ID: 19615859
[TBL] [Abstract][Full Text] [Related]
15. The expression of NMDA receptor 1 is associated with clinicopathological parameters and prognosis in the oral squamous cell carcinoma.
Choi SW; Park SY; Hong SP; Pai H; Choi JY; Kim SG
J Oral Pathol Med; 2004 Oct; 33(9):533-7. PubMed ID: 15357673
[TBL] [Abstract][Full Text] [Related]
16. Prognostic significance of CXCR-4 expression in oral squamous cell carcinoma.
Lee JI; Jin BH; Kim MA; Yoon HJ; Hong SP; Hong SD
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2009 May; 107(5):678-84. PubMed ID: 19272813
[TBL] [Abstract][Full Text] [Related]
17. Pharmacodiagnostic evaluation of EGFR expression in oral squamous cell carcinoma.
Diniz-Freitas M; García-Caballero T; Antúnez-López J; Gándara-Rey JM; García-García A
Oral Dis; 2007 May; 13(3):285-90. PubMed ID: 17448210
[TBL] [Abstract][Full Text] [Related]
18. [Keratin 8 expression in mouth mucosa hyperkeratosis and squamous cell carcinoma ].
Babichenko II; Grigor'ian AS; Katushkina AA
Arkh Patol; 2011; 73(6):18-21. PubMed ID: 22379894
[TBL] [Abstract][Full Text] [Related]
19. Toll-like receptors -4 and -5 in oral and cutaneous squamous cell carcinomas.
Omar AA; Korvala J; Haglund C; Virolainen S; Häyry V; Atula T; Kontio R; Rihtniemi J; Pihakari A; Sorsa T; Hagström J; Salo T
J Oral Pathol Med; 2015 Apr; 44(4):258-65. PubMed ID: 25047824
[TBL] [Abstract][Full Text] [Related]
20. A role for the substance P/NK-1 receptor complex in cell proliferation in oral squamous cell carcinoma.
Brener S; González-Moles MA; Tostes D; Esteban F; Gil-Montoya JA; Ruiz-Avila I; Bravo M; Muñoz M
Anticancer Res; 2009 Jun; 29(6):2323-9. PubMed ID: 19528498
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
